Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T19:55:36.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the site. The previously displayed funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:47:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations was added, including a directive to check cc.nih.gov and opm.gov for updates. The revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T07:00:32.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Show glossary option has been added and the page revision updated to v3.4.0, with minor capitalization changes to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:32:47.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 in place of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:42:06.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations section restructured with new regional headings and entries (California, Victoria, Estado de Bahia, Pernambuco, Rio Grande do Sul, São Paulo, Ontario, Quebec, Campania, Emilia-Romagna, Bashkortostan Republic, Madrid), and removal of the previous region-specific headers such as 'California Locations' and 'Victoria Locations'.
    Difference
    0.9%
    Check dated 2025-12-23T20:29:23.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.